Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry.
acute coronary syndrome
broken heart syndrome
cancer
malignancy
outcome
takotsubo syndrome
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
06 08 2019
06 08 2019
Historique:
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
5
1
2021
Statut:
ppublish
Résumé
Background Clinical characteristics and outcomes of takotsubo syndrome (TTS) patients with malignancy have not been fully elucidated. This study sought to explore differences in clinical characteristics and to investigate short- and long-term outcomes in TTS patients with or without malignancy. Methods and Results TTS patients were enrolled from the International Takotsubo Registry. The TTS cohort was divided into patients with and without malignancy to investigate differences in clinical characteristics and to assess short- and long-term mortality. A subanalysis was performed comparing long-term mortality between a subset of TTS patients with or without malignancy and acute coronary syndrome (ACS) patients with or without malignancy. Malignancy was observed in 16.6% of 1604 TTS patients. Patients with malignancy were older and more likely to have physical triggers, but less likely to have emotional triggers compared with those without malignancy. Long-term mortality was higher in patients with malignancy (P<0.001), while short-term outcome was comparable (P=0.17). In a subanalysis, long-term mortality was comparable between TTS patients with malignancies and ACS patients with malignancies (P=0.13). Malignancy emerged as an independent predictor of long-term mortality. Conclusions A substantial number of TTS patients show an association with malignancy. History of malignancy might increase the risk for TTS, and therefore, appropriate screening for malignancy should be considered in these patients. Clinical Trial Registration URL: http://www.clinicaltrial.gov. Unique identifier: NCT01947621.
Identifiants
pubmed: 31311438
doi: 10.1161/JAHA.118.010881
pmc: PMC6761645
doi:
Banques de données
ClinicalTrials.gov
['NCT01947621']
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e010881Commentaires et corrections
Type : CommentIn
Références
Eur Heart J. 2018 Jun 7;39(22):2032-2046
pubmed: 29850871
J Am Coll Cardiol. 2016 Apr 26;67(16):1937-40
pubmed: 27102509
Eur Heart J. 2018 Jun 7;39(22):2047-2062
pubmed: 29850820
Heart Lung. 2011 Sep-Oct;40(5):472
pubmed: 20723983
Eur J Heart Fail. 2008 Oct;10(10):1015-9
pubmed: 18692439
NPJ Precis Oncol. 2017 Sep 12;1(1):31
pubmed: 29872712
Circ J. 2016 Sep 23;80(10):2192-8
pubmed: 27581345
Heart Lung. 2011 May-Jun;40(3):270
pubmed: 20832864
Int J Cardiol. 2017 Jul 1;238:159-165
pubmed: 28318661
Heart Lung. 2010 May-Jun;39(3):188-95
pubmed: 20457338
BMC Pediatr. 2016 Jul 19;16:99
pubmed: 27435703
Ann Intern Med. 2010 Jun 15;152(12):830-1
pubmed: 20547921
J Am Coll Cardiol. 2018 Aug 21;72(8):874-882
pubmed: 30115226
Oxf Med Case Reports. 2016 Apr 07;2016(4):55-8
pubmed: 27066260
Circ J. 2016 Dec 22;81(1):124
pubmed: 27928129
Heart. 2014 Nov;100(22):1804-12
pubmed: 24711482
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Heart Fail Clin. 2013 Apr;9(2):233-42, x
pubmed: 23562124
Heart. 2017 Sep;103(18):1461-1469
pubmed: 28839096
Ann Oncol. 2003 Feb;14(2):313-22
pubmed: 12562661
Circulation. 2008 Dec 16;118(25):2754-62
pubmed: 19106400
J Am Coll Cardiol. 2016 Sep 6;68(10):1143-4
pubmed: 27585514
Heart Fail Clin. 2016 Oct;12(4):597-603
pubmed: 27638029
J Am Heart Assoc. 2019 Aug 6;8(15):e010881
pubmed: 31311438
Am Heart J. 2008 Mar;155(3):408-17
pubmed: 18294473